MC4R raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-19. Anything still debated is marked as such rather than presented as settled.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
Lyophilized peptide arrives as a white to off-white cake or powder and is normally held at minus twenty degrees Celsius or colder for extended periods. Short-term bench work at ambient temperature is tolerable for minutes, not hours, because the solid is hygroscopic and picks up moisture that promotes hydrolysis. Vials should stay in a desiccator or a sealed bag with desiccant, protected from light, since aromatic residues in the sequence are susceptible to photo-oxidation. Inventory records that note arrival date and storage location reduce the chance of using degraded material.
Reconstitution is usually performed with sterile water or a dilute acetic acid solution, and the choice of solvent affects both dissolution speed and final pH. Complete dissolution should be confirmed by visual inspection before any aliquot is taken, since undissolved particles can concentrate in the sampling volume. Repeated freeze-thaw cycles are the most common cause of gradual loss of purity, so dividing a stock into single-use aliquots at the first opportunity is standard practice. Working solutions kept refrigerated are generally used within days rather than weeks.
| Property | Value | Notes |
|---|---|---|
| Research code | PT-141 | Used in early literature before the generic name became common |
| Generic name | Bremelanotide | International nonproprietary name |
| Peptide class | Cyclic heptapeptide | Seven residues joined by a lactam bridge |
| Primary receptor | MC4R | Lower affinity reported at MC1R, MC3R and MC5R |
| Route studied clinically | Subcutaneous injection | Intranasal route was abandoned after pressor effects |
Published studies differ in design, population and endpoint definition, so results are not always directly comparable across reports. Some trials used patient-reported measures of desire and distress, while others tracked physiological or behavioural outcomes. Questions that remain open include the durability of effects beyond short follow-up periods, the frequency of transient blood pressure elevation observed after administration, and whether a subtype-selective analogue could separate central effects from pigmentation-related activity. These points are usually framed as unresolved rather than settled in review literature.
Routine characterisation of bremelanotide relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nm, where the peptide backbone absorbs. Mass spectrometry, typically in tandem mode with electrospray ionisation, confirms identity and supports quantification in biological matrices. Additional checks include amino acid analysis, peptide mapping after enzymatic digestion, and confirmation of the lactam bridge, since incomplete cyclisation produces a mass-shifted by-product. Purity values above 95 percent are common in reference-grade material, though reports vary in how strictly related substances are resolved from the parent peak.
The lyophilised solid is relatively stable when kept dry, protected from light and held at reduced temperature, commonly minus 20 degrees Celsius or lower for long-term storage. In solution the peptide is more vulnerable: tryptophan oxidation, hydrolysis of the lactam bridge and aggregation all become relevant over time, and the rate depends on pH, buffer composition and concentration. Repeated freeze-thaw cycles are generally avoided because they promote aggregation. Aqueous working solutions are typically prepared fresh or split into single-use aliquots to limit degradation before analysis.
Bremelanotide is a cyclic heptapeptide that binds several melanocortin receptors rather than one. In vitro assays report agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R generally treated as the subtype most relevant to sexual effects. MC4R is expressed in hypothalamic nuclei involved in appetite, energy balance and motivated behaviour, which provides a plausible route for central action. Selective MC4R agonists studied in animals produce comparable behavioural changes, supporting that interpretation.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
Melanocortin receptors form a family of five G-protein-coupled proteins, labelled MC1R through MC5R, that respond to peptides derived from pro-opiomelanocortin. Alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone are the best-known endogenous ligands. The receptors are distributed differently across tissues, so a single agonist can produce effects in the brain, skin, adrenal gland and vasculature. This distribution explains why one peptide can influence both pigmentation and motivated behaviour.
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
"Chorionic gonadotropin+beta [HCG];Csv";"Csv-Chorionic gonadotropin+beta chain; arb.stofk.(IS 75/589)";Clinical Biochemistry Laboratory "alpha-1-Fotoprotein;Csv";"Csv-alpha-1-Fotoprotein; arb.stofk.";Clinical Biochemistry Laboratory "Tick-borne encephalitis virus antibody; arb.k.(list; proc.);Csv";Tick-borne encephalitis virus antibody; Clinical Microbiology Laboratory "Cerebrospinal fluid group;Csv";"Csv-Nucleated cell type; count(list)";Clinical Biochemistry Laboratory "Erythrocytes;Csv";"Csv-Erythrocytes; count";Clinical Biochemistry Laboratory "Nucleated cells;Csv";"Csv-Nucleated cells; count";Clinical Biochemistry Laboratory "Nucleated cells;Csv";"Csv-Nucleated cells; count";Clinical Biochemistry Laboratory "Leukocytes(mononuclear);Lkc(Csv)";"Csv-Mononuclear cells; count";Clinical Biochemistry Laboratory "Leukocytes(mononuclear);Lkc(Csv)";"Csv-Leukocytes(mononuclear); count";Clinical Biochemistry Laboratory "Leukocytes (polynucleus);Lkc(Csv)";"Csv-Leukocytes(polynucleus); count";Clinical Biochemistry Laboratory "Leukocytes (polynuclear);Lkc(Csv)";"Csv-Polynuclear cells; count";Clinical Biochemistry Laboratory "Neurofilament light polypeptide;Csv";Csv(cell-free);Neuroimmunology Laboratory "Glucose;Csv";"Csv-Glucose; substance c.";Clinical Biochemistry Laboratory Alternatively formatted list: The following analyses (Normal Order Name; Designation in the laboratory; Laboratory) can be performed on cerebrospinal fluid (CSF) samples.
== Side effects and tolerance == Side effects increase with dosage, and include drowsiness, mild stomach ache, lethargy, urinary retention, bradypnea, constipation, nausea, respiratory depression, and death. Nausea can be attributed to the presence of noscapine. At high doses, the side effects are dangerous and can cause death through hypoventilation or pulmonary aspiration of vomit. Symptoms of withdrawal include diarrhea, vomiting, sweating, anxiety, rhinorrhea, agitation, seizures.
They also extend into, but are not destined to supplant, systems biology models of metabolic pathways. They are also parallel to physiome models, but do not aim at modelling physiological functions beyond fluid circulation in detail. In fact the above four types of models can reinforce each other when integrated.
=== Seed germination === There are two types of seed within each pod – reddish-dark and dark (black). The ratio between these seeds varies from 1:20 to 1:5, with darker seeds outnumbering lighter seeds. Reddish-dark seeds have a thinner coat and they germinate earlier than black seeds that have not first been acid treated. "Dark seeds have a harder seed coat and require various pretreatments to ensure good germination rates." Although the seeds' usual germination rate has been reported at 75%, germination can be improved by scalding for about 7 minutes, then soaking seeds in hot water overnight prior to planting. Locust tree seedlings "can be established vegetatively in nursery beds by grafting or budding, or by rooting adult cuttings." These methods have shown good results in 11- to 25-year-old trees in Burkina Faso and Nigeria.
The previous life: the first two nidanas, namely ignorance and mental fabrications. They are basis for the events in the present. Nyanatiloka, writing from a traditional Theravada perspective, calls these "karma process" (kamma-bhava). The present life: The third to the tenth nidanas (consciousness, nama-rupa, the sense bases, contact, feeling, craving, clinging, becoming) relate to the present life. This begins with the descent of vijnana (consciousness, perception) into the womb. Nyanatiloka notes that nidanas 3-7 are part of the "rebirth process" (uppatti-bhava) and nidanas are 8-10 are "karma process". The future life: The last two nidanas (birth, old age and death) represent the future lives conditioned by the present causes. Nyanatiloka states these last two nidanas are a "rebirth process". Bhikkhu Bodhi notes that this distribution of the 12 nidanas into three lives "is an expository device employed for the purpose of exhibiting the inner dynamics of the round. It should not be read as implying hard and fast divisions, for in lived experience the factors are always intertwined." Furthermore, Bodhi argues that these twelve causes are not something hidden, but are "the fundamental pattern of experience" which "always present, always potentially accessible to our awareness." Nagarjuna's Pratityasamutpada-hrdaya-karika also outlines the 12 nidanas as a rebirth process.
Sources: en.wikipedia.org
===== MHCII presentation ===== In MHCII presentation, HSPs are involved in clathrin-dependent endocytosis. Also when HSPs are extracellular, they can guide their associated peptides into MHCII pathway, although it is not known how they are distinguished from the cross-presented ones (see below).
Marxism–Leninism–Maoism–Prachanda Path (Nepali: मालेमावाद र प्रचण्डपथ Mālemāvād ra Prachaṇḍapath; sometimes shortened to Prachanda Path) is the ideological line of the Communist Party of Nepal (Maoist Centre), also known as the CPN (MC). It is considered a development of Marxism–Leninism–Maoism (MLM) and named after the leader of the CPN (MC), Pushpa Kamal Dahal, commonly known as Prachanda. Prachanda Path was proclaimed in 2001. The ideology was partially inspired by the example of the Communist Party of Peru – Shining Path, which refers to its ideological line as Marxism–Leninism–Maoism–Gonzalo Thought. Prachanda Path does not claim to make an ideological break with Marxism, Leninism or Maoism, but rather to be an extension of these ideologies based on the politics of Nepal. The doctrine came into existence after the party determined that the ideologies of Marxism, Leninism and Maoism could no longer be practiced completely as they had been in the past. The party adopted Prachanda Path as they felt it was a suitable ideology based on the reality of Nepalese politics. Militarily and in the context of the 1996–2006 civil war in Nepal, central to the ideology was the achievement of revolution through the control of rural areas and the encirclement of urban settlements. The CPN (MC) was seen to have abandoned Maoism in its decision to merge with the Communist Party of Nepal (Unified Marxist–Leninist) to form the Nepal Communist Party, but this party has since been disestablished and the CPN (MC) reconstituted.
The Christian Science movement is a religious movement within Christianity founded by Mary Baker Eddy that arose in the mid to late 19th century and that led to the founding of The First Church of Christ, Scientist.
Between 12 and 14 June, Datafolha interviewed another 2,010 people in 112 Brazilian municipalities, and the Lula government received a good or excellent rating from 37% of respondents, regular from 33%, and bad or terrible from 27%. Three percent of respondents did not express an opinion. According to the survey, Lula's third term maintained a good "balance" of approval and regular ratings over five months, surpassing the ratings of the previous governments of Collor, Temer and Bolsonaro, but still being surpassed by the ratings of the first-term governments of FHC and Dilma. Between 15 and 18 June, the Genial/Quaest institute interviewed 2,029 voters over the age of 16, and the survey showed an increase in the rating from 51% to 56% again compared with the survey released in April of that year. That percentage represents those who said that Lula governs the country well, and the decrease from 42% to 40% represents those who said that Lula governs the country badly. From the end of June to the beginning of July, Lula's third government was measured by the newspaper PoderData, with 2,500 respondents from 262 municipalities across the country, ending the first half of the year with a "balance" in approval. Fifty-one percent of respondents rated Lula's administration positively, while 43% disapproved of the administration and 6% did not know how to rate it. The newspaper also asked respondents how they rated Lula governing the country, and in 3 months the percentage for good governance rose by two points (from 39% to 41%).
=== Preclinical development === Several ASOs are currently being investigated in disease models for Alexander disease, ATXN2 (gene) and FUS (gene) amyotrophic lateral sclerosis, Angelman syndrome, Lafora disease, lymphoma, multiple myeloma, myotonic dystrophy, Parkinson's disease, Pelizaeus–Merzbacher disease, and prion disease, Rett syndrome, spinocerebellar Ataxia Type 3.
Sources: en.wikipedia.org
=== Analogues === Analogues of muscimol include γ-aminobutyric acid (GABA), ibotenic acid, dihydromuscimol, thiomuscimol, piperidine-4-sulphonic acid (P4S), gaboxadol (THIP), 4-AHP, 4-PIOL, isonipecotic acid, guvacine, isoguvacine, THPO, nipecotic acid, and tiagabine, among others. In contrast to the preceding compounds, certain other analogues, including isomuscimol and azamuscimol, are virtually inactive. The structural requirements for GABAA receptor binding and activation are very strict, so relatively few high-efficacy GABAA receptor agonists are known.
=== 13 April === The BBC reported that the UK plans to send a third Westland Sea King helicopter to Ukraine in the "coming weeks", with the Ukrainian crew being trained in its maintenance at a base in "southern England".
Heparin is given parenterally because it is not absorbed from the gut, due to its high negative charge and large size. It can be injected intravenously or subcutaneously (under the skin); intramuscular injections (into muscle) are avoided because of the potential for forming hematomas. Because of its short biologic half-life of about one hour, heparin must be given frequently or as a continuous infusion. Unfractionated heparin has a half-life of about one to two hours after infusion, whereas LMWH has a half-life of four to five hours. The use of LMWH has allowed once-daily dosing, thus not requiring a continuous infusion of the drug. If long-term anticoagulation is required, heparin is often used only to commence anticoagulation therapy until an oral anticoagulant e.g. warfarin takes effect. The American College of Chest Physicians publishes clinical guidelines on heparin dosing.
=== Australia === Salvia divinorum is considered a Schedule 9 prohibited substance in Australia under the Poisons Standard. Under the Standard, schedule 9 prohibited substances are defined as "Substances which may be abused or misused, the manufacture, possession, supply or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities."
Sources: en.wikipedia.org
The code designates bremelanotide, a cyclic heptapeptide melanocortin receptor agonist. It served as an internal research identifier before the compound entered formal clinical development. The code and the generic name refer to the same molecule.
MC4R is generally described as the principal target, based on binding affinity and functional assays. Activity at MC1R, MC3R and MC5R is reported as weaker. Receptor selectivity is one reason the compound was pursued for central rather than vascular effects.
Both are synthetic melanocortin analogues built on a similar cyclic peptide scaffold. Bremelanotide is described in the literature as a metabolite-derived analogue of melanotan II rather than the same substance. The two differ in terminal modifications, which affect half-life and receptor profile.
Cold storage at minus twenty degrees Celsius or below is typical, with desiccant and protection from light. The solid form is far more stable than any solution.